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The aging process is characterized by gradual changes to an organism’s macromolecules, which neg-
atively impacts biological processes. The complex macromolecular structure of chromatin regulates
all nuclear processes requiring access to the DNA sequence. As such, maintenance of chromatin
structure is an integral component to deter premature aging. In this review, we describe current
research that links aging to chromatin structure. Histone modiﬁcations inﬂuence chromatin com-
paction and gene expression and undergo many changes during aging. Histone protein levels also
decline during aging, dramatically affecting chromatin structure. Excitingly, lifespan can be
extended by manipulations that reverse the age-dependent changes to chromatin structure, indicat-
ing the pivotal role chromatin structure plays during aging.
 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction tions to macromolecules that promote aging will be critical to de-The basic repeating unit of chromatin, the nucleosome, consists
of just under 150 bp of DNA wrapped around an octamer of histone
proteins including two molecules of each core histone – H2A, H2B,
H3, and H4 [1]. The addition of linker histones and non-histone
proteins enables the folding of arrays of nucleosomes into 30 nm
ﬁbers and higher order chromatin structures. Packaging of our
DNA into chromatin regulates all the genomic processes that occur
within the cell. The reason for this is that the degree of chromatin
compaction determines accessibility to the underlying DNA se-
quences. Tightly structured chromatin, or heterochromatin, mini-
mizes genomic instability and misregulated gene expression,
whereas more open chromatin, known as euchromatin, facilitates
increased gene expression and genomic instability.
Aging is the prime risk factor for many human diseases such as
cancer, heart disease, and diabetes. As such, elucidating the altera-chemical Societies. Published by E
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Holcombe Blvd, Houston, TXvelop treatments to delay or minimize age-related diseases and
potentially extend lifespan. Aging is accompanied by changes in
the transcriptional proﬁle of cells and increased genomic instabil-
ity [2,3]. The reasons for these age-related changes remain unclear
but given that chromatin structure regulates genomic integrity and
gene expression, potential changes to the chromatin structure dur-
ing aging are likely to play an important role. Indeed, it has been
previously suggested that changes to chromatin structure may par-
tially explain the age-related changes to biological functions in
cells and the increased incidence of disease states with age [4,5].
Chromatin structure is modiﬁed by the cell in a variety of ways
to facilitate or limit access to the DNA. The most profound alter-
ation to chromatin structure consists of the removal of histones
from DNA and the opposite process of re-deposition of histones
onto the DNA to re-establish chromatin. Another way to alter chro-
matin structure is via the addition or removal of post-translational
modiﬁcations (PTMs) on speciﬁc amino acid residues on the his-
tones. Histone PTMs exist in complex patterns including phosphor-
ylation, acetylation, methylation and ubiquitination. PTMs on
histones and DNA methylation of cytosines (collectively referred
to as epigenetic marks) inﬂuence the ability of proteins to bind
to the chromatin [6] which subsequently regulates the degree of
compaction of the chromatin structure and the activities of the
genome. For example, normal patterns of epigenetic marks are re-
quired for growth, development and the prevention of human dis-
ease. Growing evidence indicates that the patterns of epigenetic
marks are altered during aging and human disease states including
cancer [7]. In contrast to the genetic changes to the DNA sequence,lsevier B.V. All rights reserved.
Table 1
Comparison of histone variants and modiﬁcations that change with age. Compilation
of known changes to the abundance of histone modiﬁcations and histone variants
that change from young to old organisms (in vivo) or cells (in vitro).
Modiﬁcation Change with
age
Organism Citation
Global histone
acetylation
Decrease Human (in vitro) [50]
Bulk H4 ac Decrease Rat (in vivo) [65]
H3 K9me Increase Human (in vitro) [53]
H3 K9me2 Decrease Human (in vitro) [53]
H3 K9me3 Decrease Human (in vivo)
(in vitro)
[45]
[53]
Increase Mouse (in vivo) [66]
Increase Fly (in vivo) [71]
H3 K9ac Decrease
Increase
Rat (in vivo)
Human (in vitro)
[67]
[53]
H3 S10ph Increase,
Decrease
Rat (in vivo)
Human (in vitro)
[67]
[53]
H3 K14ac Increase Mouse (in vivo) [68]
H3 K27me3 Decrease Human (in vitro),
Mouse (in vitro)
[69]
H4 K8ac Increase Mouse (in vivo) [68]
H4 K12ac Increase Mouse (in vivo) [68]
H3 K56ac Decrease Yeast (in vivo),
Human (in vitro)
[17]
[53]
H4 K16ac Increase Yeast (in vivo),
Human (in vitro)
[17]
[53]
H4 K20me Increase Human (in vitro) [53]
H4 K20me2 Increase Human (in vitro) [53]
H4 K20me3 Increase
Decrease
Rat (in vivo)
Human (in vitro)
[51]
[53]
H3.1 Decrease Human (in vitro)
Rat (in vivo)
[59]
[70]
H3.2 Decrease Rat (in vivo) [70]
H3.3 Increase Human (in vitro)
Rat (in vivo)
[59]
[70]
H2A.1 Decrease Human (in vitro)
Rat (in vivo)
[59]
[70]
H2A.2 Increase Human (in vitro)
Rat (in vivo)
[59]
[70]
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ising therapeutic target for the treatment of human disease and
hold equally promising potential for delaying the aging process.
Long-term maintenance of chromatin structure is required to
promote normal biological functions during the aging process.
Individuals with Hutchinson-Gilford progeria syndrome (HGPS),
exhibit early aging characteristics such as hair-loss, decreased joint
mobility, and heart disease that represent at least a subset of age-
related problems [8]. Noteworthy, HGPS is accompanied by dis-
rupted chromatin structure and nuclear organization. Moreover,
the accelerated changes to the chromatin structure that occur in
HGPS partially mirror the changes that occur normally in aged hu-
mans, suggesting a causal link between altered chromatin struc-
ture and aging.
In this review we will discuss the changes to chromatin struc-
ture that occur with age in multiple organisms and discuss recent
publications that further demonstrate how chromatin structure
impacts aging. Aging is accompanied by gross changes in DNA
methylation, but this will not be discussed further here as this sub-
ject has been covered comprehensively in recent reviews [9,10].
Rather, we will summarize the changes to histone PTMs, and
changes in the abundance of histone proteins, histone variants
and non-histone chromatin proteins during aging. These and fu-
ture studies will enable the ﬁeld to answer many of the remaining
questions, such as what are all the age-related changes to chroma-
tin? Which of the age related changes to chromatin cause aging?
Which of the age related changes to chromatin function to delay
premature aging?Which age related chromatin changes are simply
a consequence rather than a cause of aging? We will also summa-
rize very recent reports showing manipulations to chromatin
structure can reverse age related changes and delay the aging pro-
cess, demonstrating that the changes to the chromatin structure
during aging are indeed a cause of aging.
2. Chromatin modulation and aging in yeast
The budding yeast Saccharomyces cerevisiae has become a lead-
ing model organism for the study of aging as a consequence of the
ease of its genetic manipulation, short cell division cycles, accuracy
of lifespan determination and conservation of aging mechanisms
across eukaryotes. One measurement of aging in budding yeast is
the replicative lifespan (RLS), which is the number of times mother
cells can divide to form daughter cells, modeling the ﬁnite mitotic
divisions that occurs in metazoan cells. One of the ﬁrst hints that
chromatin structure changes during aging came from the realiza-
tion that replicative aging in yeast is accompanied by the loss of
transcriptional silencing which is thought to reﬂect a decrease in
the degree of chromatin compaction [11].
Budding yeast maintain silencing in three main regions of the
genome: the telomere proximal regions, the mating-type loci,
and the ribosomal DNA (rDNA). Silencing of mating-type loci
prevents sterility from occurring, which happens when gene
products for both mating types are simultaneously expressed,
preventing the cell from responding to mating pheromone. Aged
yeast experience increased sterility due to the loss of silencing of
the mating-type loci and subsequent expression of both mating-
types [11]. Regions that contain repetitive DNA sequences such
as the rDNA and telomere proximal DNA are silenced, which
helps to prevent recombination, genomic instability and the for-
mation of extra ribosomal chromosomal circles (ERCs). Silencing
of reporter genes inserted near telomeres is lost upon replicative
aging [12]. This occurs concomitantly with the movement of
silencing proteins, including the NAD-dependent histone deace-
tylase (HDAC) Silencing information regulator 2 (Sir2), away
from telomeric regions to the rDNA [13]. Failure to silence the
rDNA results in higher levels of recombination and the formationof ERCs. Noteworthy, ERCs accumulate with age and can limit
the RLS of yeast [14].
Sir2 mediated silencing of chromatin inﬂuences the RLS. Dele-
tion of SIR2 reduces the RLS, while introducing an extra genomic
copy of SIR2 extends the RLS, indicating that Sir2 is a limiting factor
during aging [15]. Although the exact nature of the changes to the
chromatin structure during aging were not clear, the increased
genomic instability, the accumulation of ERCs, the loss of silencing
with age and the ability of the Sir2 HDAC to inﬂuence yeast RLS
were highly suggestive of a more relaxed chromatin structure dur-
ing aging, at least at the silent regions of the genome.
2.1. Sir2 and telomeric histone acetylation
Recently, Sir2’s function as a HDAC has been shown to directly
affect aging in budding yeast. Sir2 is the primary HDAC for acety-
lated lysine 16 of histone 4 (H4 K16ac) [16]. Old yeast cells were
found to have decreased amounts of Sir2 protein compared to
young cells and this is the likely reason for increased global levels
of H4 K16ac in old cells [17] (Table 1; Fig. 1). H4 K16ac is a unique
epigenetic mark in that it inhibits the formation of the 30 nm chro-
matin ﬁber and impedes the ability of chromatin to form cross-ﬁ-
ber interactions [18]. As such, increased levels of H4 K16ac in old
cells presumably lead to a more open chromatin structure. Exam-
ination of H4 K16ac levels on the chromatin of old cells demon-
strated increased levels of H4 K16ac at the X core and X
elements within the telomeric regions examined [17]. The in-
creased level of H4 K16ac with age also correlated with decreased
silencing of reporter genes inserted near these telomere proximal
Fig. 1. Alterations to chromatin structure during aging in eukaryotes. (A) Budding
yeast undergo changes to histone levels and histone modiﬁcations with increased
replicative age. Additionally, changes to chromatin modifying proteins and organic
molecules that impact chromatin structure occur with increased age. (B) Mamma-
lian cells experience changes in histone modiﬁcations during successive mitotic
divisions in vitro. Levels of histones, histone modiﬁcations, and chromatin
modifying proteins are altered during the aging process.
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encoding the relevant histone acetyl transferase (HAT), Something
About Silencing 2 (SAS2), extended the RLS of yeast [17]. Con-
versely, mutation of H4 K16 to glutamine, which mimics perma-
nent acetylation, decreased the RLS, directly showing that H4
K16ac modulates lifespan in budding yeast. As such, the ability of
Sir2 to reduce H4 K16Ac levels partially explains the mechanism
by which Sir2 promotes lifespan in budding yeast, though how life-
span is shortened as a consequence of loss of telomere-proximal
silencing due to increased H4 K16ac remains unclear. As H4
K16ac inhibits higher order chromatin formation [18], the short-
ened lifespan of yeast with excess H4 K16Ac (achieved by deletion
of the SIR2 gene or the K16Q mutation to mimic acetylation) could
be the result of a potentially more open global chromatin structure.
Conversely, the extended lifespan of cells with reduced levels of H4
K16ac (achieved by overexpression of the Sir2 HDAC or deletion of
the gene encoding the Sas2 HAT) could be due to a potentially
more closed global chromatin structure. Indeed, analysis of histone
H4 occupancy by chromatin immunoprecipitation (ChIP) analysis
on DNA in mutants with altered H4 K16ac levels is consistent with
these predictions [17].
2.2. Aging and loss of histones
Global age-related transcriptional changes have been docu-
mented in budding yeast. These changes in gene expression during
aging correlate with the shifts in the metabolic proﬁle, elevated
stress responses and induction of DNA repair genes [19,20]. Some
of these transcriptional changes are likely responses to the stresses
of aging itself. However, given that loss of silencing is a character-
istic of aging in budding yeast, the changes in transcription during
aging could also stem from a general reduction in the stringency of
transcriptional regulation due to chromatin alterations.Another example of altered transcription during aging occurs at
the genes encoding the core histones. Histone transcript levels in-
crease during aging in wild type (WT) yeast [20]. By contrast,
short-lived yeast deﬁcient in telomerase activity or dna2-1 mu-
tants have decreased histone transcript levels in old cells [20]. Sim-
ilarly, short-lived yeast mutants lacking the ability to acetylate H3
lysine 56 (H3 K56ac) also have reduced levels of histone tran-
scripts. For example, mutants of the histone chaperone Anti-silenc-
ing function 1 (Asf1) or the HAT, Repressor of Ty 1 transposition
109 (Rtt109), which are essential for acetylation of H3 K56, or
strains with an H3 K56A substitution that prevents acetylation of
H3 K56, all exhibit a similar decrease of histone transcripts levels
and dramatically reduced RLS [17,21,22]. Normally, H3 K56ac is
enriched at the promoters of histone genes and is required for nor-
mal transcription of the cell cycle regulated histone genes [21].
Studies at model yeast promoters have revealed the likely mecha-
nism whereby H3 K56ac promotes transcription of the histones
genes – H3 K56ac promotes the disassembly of histone proteins
from promoters to facilitate access by the transcriptional machin-
ery [23]. Furthermore, while aged WT yeast have elevated histone
transcript levels, cells lacking the ability to acetylate H3 K56 fail to
increase histone transcripts with age [22]. Counterintuitive to the
role of H3 K56ac in promoting histone transcription and the in-
crease in histone transcription that occurs during aging inWT cells,
bulk levels of acetylated H3 K56 (H3 K56ac) actually decreased
with age [17] (Fig. 1, Table 1). This could suggest that the bulk lev-
els of H3 K56ac in the cell are not reﬂecting the occupancy of H3
K56ac at the promoters of the histone genes, or that other mecha-
nisms are acting to promote histone transcription in old cells de-
spite the reduced level of H3 K56ac. Notwithstanding, given the
role of H3 K56ac in promoting rapid and efﬁcient gene expression,
the reduction in bulk H3 K56ac levels in old cells could exacerbate
and potentially contribute to other age-related transcriptional
changes.
In contrast to the increase in histone transcript levels during
aging, investigation of total histone protein levels in aged cells
found H3, H4 and H2A protein levels to be greatly reduced relative
to young cells [17,22] (Figs. 1 and 2). Perhaps the increase in his-
tone transcripts that normally occurs during aging reﬂects a feed
back mechanism to attempt to replace the histone proteins that
are lost during aging. Additionally, the occupancy of histones on
DNA declines in aged yeast relative to young populations as dem-
onstrated by ChIP and chromatin fractionation experiments
[17,22]. The loss of histone occupancy during aging occurred from
many different genomic locations and included the silent regions
near telomeres, the rDNA, and the mating-type loci but also in-
cluded the promoter of a repressed gene (PHO5) (JF and JT unpub-
lished data) and open reading frame of an active gene ACT1.
Although this loss of histones during aging has not yet been dem-
onstrated at every region of the genome, all regions sampled to
date show a profound loss of histones during aging. Additionally,
it is unlikely that the loss of histones that has been observed during
aging merely reﬂects the accumulation of a dead cell population in
the culture that for some reason completely lack any histones, be-
cause yeast cells exist in a metabolically active senescent state for
an extremely long time after ceasing replicative divisions [24]. The
transcriptional consequences of loss of histone proteins from the
genome are likely to be profound. For example, experimental
depletion of H4 alters transcription of many genes, particularly
those near telomeric regions [25].
The loss of histone proteins during aging raises the question of
whether loss of histones during aging is a cause of aging. Clearly
there is a correlation between histone protein levels and lifespan
in some mutants. For example the loss of histone protein occu-
pancy on the DNA occurs after fewer generations in the asf1D
and rtt109D mutants than in aged WT yeast [22], providing a
Fig. 2. Histones levels decline during aging. Young budding yeast cells have high
levels of histones that facilitates proper chromatin assembly and histone exchange.
With increasing age, histone levels decline, which may cause chromatin to be more
open and have reducing histone exchange. This potentially leads to inappropriate
access to the DNA, disrupting transcriptional regulation. Increasing the histone
supply may allow the formation of tighter chromatin structure, thereby restoring
transcriptional regulation and causing lifespan to be extended.
Fig. 3. Spermidine treatment extends lifespan via chromatin alterations. During
aging, yeast experience a decline in polyamine levels that disrupts cellular functions
and leads to necrotic death. The addition of spermidine causes a global decrease in
H3 N-terminal acetylation and increases the expression of autophagic genes.
Autophagic responses reduce the accumulation of damaged molecules and delay
the onset of necrosis, extending lifespan.
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occupancy on the genome. Indeed, increasing the expression of
H2A and H2B in short-lived asf1D mutants partially restored the
lifespan [22], indicating that the low histone level is partially
responsible for the decreased lifespan of the asf1D mutant. Fur-
thermore, disruption of the histone information regulator complex
(Hir), which is a repressor of histone transcription, causes elevated
histone transcript levels and results in higher levels of H3 protein
in aged hir1Dmutants [22]. Indeed, the RLS of hir1Dmutants is in-
creased relative to WT yeast [22]. The ultimate demonstration of a
causal link between histone levels and aging was provided by the
almost 50% increase in RLS that was achieved by inducing elevated
levels of histones H3/H4 driven by the divergent pGAL1/10 pro-
moters (Fig. 2) [22]. Noteworthy, this degree of lifespan extension
is greater than that achieved by any known single manipulation in
yeast, including calorie restriction.
The profound loss of histone proteins in aged yeast is expected
to lead to a more open chromatin structure. A more open chroma-
tin structure in turn would enable inappropriate access of the tran-
scription machinery and DNA damaging agents to the DNA [26,27]
(Fig. 2). Noteworthy, given that daughter yeast are rejuvenated, i.e.
their age clock is set back to 0, the accumulation of mutations in
the mother’s genome is unlikely to be the major driving force that
determines the RLS of yeast. The increased access of the transcrip-
tion machinery to the DNA that likely results from histone loss
with age may lead to elevated transcription of some genes (this
could also explain the age-dependent increase in histone transcrip-
tion), transcription of genes that should normally be repressed and
the use of cryptic initiation sites in old cells. Clearly, these ideas
now need to be thoroughly tested.
Throughout the cell cycle, histone proteins constantly leave the
chromatin and are replaced, or ‘‘exchanged’’, with free histone pro-
teins. One could imagine that the lower concentration of histones in
old cells is likely to lead to a smaller pool of free histones, which
would limit the extent of histone exchange (Fig. 2). If histone ex-
change is indeed reduced in old cells, this would limit the cells
capacity to refresh the histonemodiﬁcation pattern on the genome,and may contribute to the alterations in patterns of epigenetic
markswith age (Table 1, Fig. 1). The consequence of reduced histone
exchange would again be altered gene expression during aging.
Given that overexpressing histones can extend lifespan [22], it
is tempting to speculate that the additional histones can restore
the occupancy of histones on the DNA in old cells in order to rein-
state the stringency of transcriptional regulation (Fig. 2). Extra his-
tones may also restore the rates of histone exchange in old cells, in
order to prevent the age-dependent accumulation of detrimental
histone modiﬁcations such as H4 K16ac on the genome. In this
case, overexpression of histones would be expected to rejuvenate
the chromatin structure and genomic functions of old cells back
to that of young cells. Regardless of the mechanism, it is clear that
increasing histone expression and reducing levels of H4 K16ac im-
proves lifespan, indicating that the maintenance of chromatin
structure is central to the aging process in budding yeast.
2.3. Spermidine treatment reduces N-terminal H3 acetylation to
extend lifespan
Further evidence indicating a link between histone modiﬁca-
tions, chromatin maintenance, and aging is found through the ef-
fect of the polyamine spermidine on lifespan. Polyamines are
small organic molecules derived from amino acids and are synthe-
sized by all organisms. Polyamines promote cell proliferation and
inhibit apoptosis and have been implicated in cancer because poly-
amine levels are increased in cancer [28]. Aged mammalian cells
and old yeast have decreased levels of polyamine synthesis and
subsequently decreased levels of polyamines (Figs. 1 and 3). Yeast
subjected to spermidine supplementation have increased chrono-
logical lifespan and RLS [29] (Fig. 3). Treatment with spermidine
resulted in hypoacetylation of H3 K9, K14, and K18 during chrono-
logical aging by an apparent inhibition of HAT activity. Inactivation
of HATs that acetylate H3 K9, K14, and K18 also extended RLS and
reduced the response to spermidine treatment, indicating that
lowering the levels of H3 N-terminal acetylation partially explains
the mechanism whereby spermidine treatment extends lifespan
[29]. The ability of reduced levels of H3 N-terminal acetylation
and reduced levels of H4 K16Ac to extend lifespan is in contrast
to the extended lifespan that results from increasing levels of H4
K5Ac and H4 K12Ac by deletion of the gene encoding the HDAC
Rpd3 [30]. It is clear that not all lysine acetylations within the N-
termini of histones are equivalent for lifespan extension, and this
is probably explained by differences in the genes whose transcrip-
tion are inﬂuenced by different histone acetylation marks.
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sion, microarray analyses were performed in an attempt to identify
genes whose expression is altered by spermidine treatment [29]. It
was noted that several genes required for autophagy, such as ATG7,
were upregulated (Fig. 3). Autophagy is the major lysosomal degra-
dation pathway that recycles damaged and potentially harmful cel-
lular material [31]. Autophagy counteracts cell death and extends
lifespan in various models of aging [32,33]. Indeed, yeast treated
with spermidine exhibited elevated signs of autophagy and a
reduction of necrosis, which is implicated in regulating lifespan
via the Tor pathway [29,34] (Fig. 3). Importantly, lifespan exten-
sion by spermidine treatment was not speciﬁc to yeast but also ex-
tended lifespan in Drosophila melanogaster, Caenorhabditis elegans,
mice, and human cultured cells [29]. Furthermore, autophagy
was required for lifespan extension by spermidine treatment in
yeast, ﬂies, and worms while spermidine treatment also induced
autophagy in human cultured cells, indicating the conserved link
between spermidine treatment, lifespan extension, and autophagy
[29]. It is unclear how spermidine treatment leads to the elevated
expression of the autophagy genes, because their promoters actu-
ally become enriched in H3 K18ac marks upon spermidine treat-
ment (Fig. 3) [29]. Clearly the situation is complicated, but these
studies present intriguing causal links between chromatin struc-
ture, aging and lifespan extension..
3. Chromatin modulation during mammalian aging
Aging research in yeast has indicated that changes to the nucle-
ar architecture and chromatin structure occur during aging and
that lifespan can be positively or negatively affected by multiple
types of chromatin manipulations. These lessons may also be rele-
vant to mammalian aging. Micrococcal nuclease (MNase) digestion
ladders become less discrete during aging in mammals [35,36].
MNase cleaves DNA between nucleosomes and blurring of the
digestion ladder pattern indicates that the spacing of the nucleo-
somes may become more irregular with age. Furthermore, visual
analysis of the 30 nm ﬁbers in aging ﬁbroblasts indicates a progres-
sive loss of density, suggesting loosening chromatin structure with
age [35,36]. However, the analysis of changes to chromatin struc-
ture during aging in mammals should be revisited using improved
modern day technologies, given that early studies reported re-
duced, increased or no change in MNase digestion during aging
of metazoan cells [37,38]. Part of the reason for the contradictory
results may depend on the fraction of senescent cells in the popu-
lation and the genomic regions being studied, as some regions of
the genome in senescent cells clearly becomes heterochromati-
nized, as indicated by the formation of senescence associated het-
erochromatin foci [39]. Presumably other regions of the genome
become less compact during senescence because senescence is also
accompanied by global loss of DNA methylation and loss of perinu-
clear heterochromatin [40,41].
Similar to the loss of silencing that occurs in old yeast cells, the
ability to maintain heterochromatin also decreases in old mam-
mals, shown by less efﬁcient X-inactivation in old mice [42].
Genetic diseases, termed progeria, exist in mammals that partially
mimic the aging process at an accelerated rate. These diseases are
caused by mutations of genes involved in DNA repair, telomere
maintenance, and nuclear architecture [43]. Representing a model
for the aging process, lessons learned from progeria syndromes can
be insightful for understanding how aging occurs.
3.1. Progeria, aging, and nuclear architecture changes
HGPS greatly disrupts the nuclear architecture. HGPS can be
caused by a mutation in the gene encoding Lamin A, that leads to
defective splicing and results in a C-terminally truncated proteintermed progerin [44]. Lamin A is a component of nuclear laminae
and comprises part of the nuclear envelope. Progerin acts as a
dominant gain-of-function protein, accumulating in the nuclear
envelope and causing a number of nuclear defects including a de-
cline in heterochromatin, including loss of heterochromatin pro-
tein 1 (HP1), decreased levels of trimethylated H3 K9 (me3) and
H3 K27 me3 (markers of heterochromatin), lower levels of the
H3 K27 methyltransferase EZH2, increased transcription from peri-
centric repeats, shortened telomere length, elevated levels of DNA
damage foci, and a general disruption of nuclear organization
[41,44].
Progerin expression is even detectable at low levels in many cell
types from healthy young and old individuals [45]. Cells from aged
humans exhibit elevated levels of DNA damage foci and altered
localization of Lamin A that was similar to observations of HGPS
cells. Cells from aged humans also experience a decline in the lev-
els of HP1 protein and loss of H3 K9me3 [45], indicating that sev-
eral components of HGPS and normal aging are shared, albeit
occurring at an earlier age in HGPS. Expression of progerin is sufﬁ-
cient to induce these nuclear changes in normal cells, which in turn
recapitulates several of the phenotypes observed in HGPS [46].
Intriguingly, by correcting the splicing defect of Lamin A mRNA,
accomplished by blocking the cryptic splice site, the HGPS-like
phenotypes of cells were reversed to resemble their WT counter-
parts [47]. The abnormal nuclear shape of the cells reverted to a
normal morphology and markers of heterochromatin, HP1 protein
and H3 K9me3, were restored to near WT levels in the majority of
cells. Strikingly, cells from old healthy individuals also experienced
a reversal in cellular phenotype upon reducing the level of progerin
by removing the cryptic splice site [45]. The capacity to revert the
cellular function of progerin-containing cells and old donor cells by
reducing the level of progerin strongly indicates that maintenance
of the nuclear architecture contributes to delaying the aging pro-
cess. In light of the phenotypic reversal of old cells, which have
had time to accumulate deleterious mutations to DNA, the pheno-
typic changes observed upon reducing progerin levels point to
reversible changes to macromolecules rather than permanent
mutations to DNA as being the major cause of aging in mammals.
3.2. Reduction of nucleosome remodeling deacetylase (NURD) and
HDAC1 protein levels cause HGPS phenotypes
Further characterization of HGPS cells has elucidated additional
changes to chromatin modifying proteins that contribute to the
accelerated aging phenotype observed in HPGS. Yeast-two hybrid
screens with the region lacking in progerin identiﬁed interactions
with the histone binding proteins RBBP4 and RBBP7 [48]. RBBP4
and RBBP7 function in the NURD complex, which is involved in
chromatin modulation. HGPS cells exhibited decreased RBBP4/7
protein levels, along with lower levels of the NURD subunits
HDAC1 and MTA3 [49]. Limiting NURD function via knockdown
of various subunits in HeLa or ﬁbroblast cells caused a loss of
HP1 and H3 K9me3 along with elevated levels of DNA damage foci.
These phenotypes are characteristic of HGPS, highlighting the
importance of NURD function and chromatin modiﬁcation in HGPS.
Analysis of healthy aged cells also demonstrates a decline in levels
of the NURD subunits RBBP4/7 and HDAC1 [48]. Additional re-
search will be required to determine exactly how decreased NURD
activity causes aging phenotypes. However, it is possible that re-
duced HDAC1 levels could lead to elevated histone acetylation,
which would lead to altered transcription.
3.3. Histone modiﬁcations during mammalian aging and senescence
Changes in the abundance of histone PTMs during aging has
been investigated (Table 1). Evidence for changes in histone PTMs
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including mitotically dividing cells and post-mitotic cells. These re-
sults have sometimes been contradictory given the variety of or-
gans studied and variation between individuals. Solid studies
examining histone acetylation levels found a bulk reduction of
H4 acetylation in rat cerebral cortex neurons and cultured human
cells [50]. Levels of H4 K20 trimethylation, a marker of constitutive
heterochromatin, have been shown to increase in kidney and liver
tissue with age [51]. This mimics the increase in H4 K20 trimethy-
lation levels that is observed in HGPS [41]. An interesting charac-
terization of monozygotic twins revealed that histone acetylation
of H3 and H4 is similar for twin pairs at a young age but can change
in abundance between the twins with increased age [52]. These
studies clearly indicated that the abundance of histone modiﬁca-
tions changes during aging in mammals, meriting further study.
Improvements in mass spectrometry and modiﬁcation-speciﬁc
antibodies enabled a recent comprehensive characterization of his-
tone modiﬁcations of early passage and late passage human ﬁbro-
blast cells (Table 1, Fig. 1) [53]. Despite the fact that senescent cells
do increase in abundance with increasing organismal age as ob-
served in baboon ﬁbroblast cells [54], the relevance of the study
of entry into cell senescence in tissue culture to the process of
aging in metazoans is hotly debated and has been reviewed else-
where [55]. As such, a distinction is made in Table 1 as to whether
the studies of histone modiﬁcations in mammals were performed
in tissue culture models (in vitro) or in organisms (in vivo). The de-
creased levels of H3 K56ac and the increased level of H4 K16ac ob-
served in old yeast cells was also apparent in aged cycling human
ﬁbroblasts [53]. Furthermore, aged cycling human ﬁbroblasts
experience many changes to the levels and cell cycle patterns of
speciﬁc acetylated and methylated histone residues (Table 1,
Fig. 1) [53]. As seen in aged mammalian tissue, levels of trimethy-
lated H3 K9 decreased during aging in vitro [53]. Interestingly,Fig. 4. Persistent DNA damage signals from shortened telomeres disrupt chromatin str
chromatin modifying proteins. Successive mitotic divisions leads to shortened telomeres
disrupts chromatin structure. Reduced SLBP levels reduce the stability of the histone mR
the genome, resulting in inappropriate access to the DNA and misregulated transcription
causing protein levels and chromatin structure to be restored.there was a complete loss of H4 K20 me3 in aged cycling ﬁbro-
blasts, in contrast to the increase observed in mammalian tissues
and in HGPS. In general, many of the modiﬁcations that changed
abundance during in vitro aging are involved in heterochromatin
formation or DNA damage responses. Indeed, the large number of
histone modiﬁcations whose abundance changes during aging
complicates predictions of how, or if, each histone PTM change
contributes to alteration of nuclear processes during aging. It will
also be critical to determine whether each of these histone PTM
changes occur as a consequence of aging or play a causal role in
aging.
The abundance of histone modiﬁcations during aging is directly
affected by changes in the levels of chromatin modifying proteins
during age. In addition to the altered abundance of particular his-
tone modiﬁcations during aging, chromatin structure is likely
experiencing changes in the establishment and maintenance of
chromatin due to the reduced levels of the histone chaperones
Asf1A/B and CAF-1 during aging [53] (Fig. 4). Given that Asf1A/B
and CAF-1 participate in chromatin assembly and/or chromatin
disassembly during DNA replication, DNA repair, and transcription
[56], the declining histone chaperone levels during aging could
cause cells to less efﬁciently alter chromatin structure to facilitate
nuclear processes.
3.4. Altered histone variant abundance and reduced histone protein
levels during metazoan aging
Histone variants have differences in amino acid residues that af-
fect a diverse range of nuclear functions including DNA repair,
transcription, and recombination [57]. The relative abundance of
histone variants has been examined in various metazoans during
aging [58–60]. The most notable change with likely functional con-
sequences is the loss of the canonical histone H3.1 and H3.2 anducture. Young ﬁbroblast cells have long telomeres and high levels of histones and
that cause persistent DNA damage signals. Asf1 and CAF-1 levels are reduced which
NAs during aging. Chromatin structure is likely to be more open in some regions of
. Reactivating telomerase extends the telomeres and halts the DNA damage signal,
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aging. H3.3 exists in labile, more easily removable nucleosomes
[61], and its enrichment in old cells could itself cause transcrip-
tional changes during aging. Interestingly, aging in baboons is
accompanied by an increase in the levels of HIRA [62], the histone
chaperone involved in speciﬁcally incorporating H3.3 into
chromatin.
Reinforcing the relevance of the loss of histone proteins from
the genome observed during yeast aging, the similar result has
been observed in aging human ﬁbroblasts. Replicatively aged cells
have markedly decreased levels (50%) of H3 and H4 relative to
young cells (Fig. 4) [53]. Why would histone levels decrease during
mammalian aging? SLBP, a protein required for speciﬁc stabiliza-
tion of the histone mRNA, decreases in abundance in cells aged
in vitro, which could contribute to the decreased levels of histone
proteins in high population doubling ﬁbroblasts [53]. It is not yet
clear whether the reduced levels of SLBP1, histone chaperones
and histone modifying enzymes in old cells reﬂects a defect in
transcription and/or translation. Histone transcription occurs pri-
marily during S-phase to coincide with DNA replication. This oc-
curs as a consequence of cyclinE-Cdk2 mediated phosphorylation
of the NPAT transactivator protein of histone gene expression.
During successive replicative cycles of the human ﬁbroblast
cells, telomeres undergo gradual shortening, which causes DNA
damage signals to be persistently activated. Activation of the
DNA damage checkpoint blocks phosphorylation of NPAT, inhibit-
ing histone transcription [63]. Activation of the DNA damage
checkpoint also results in degradation of histone mRNAs [64]. With
a dramatically altered chromatin structure as a consequence of re-
duced histone levels and altered patterns of histone modiﬁcations,
aged cells would presumably experience many changes to all geno-
mic processes that are likely to be detrimental for the cell. Strik-
ingly, the reactivation of telomerase in old ﬁbroblasts not only
increased the length of telomeres but also restored the abundance
of Asf1, SLBP and histones and restored the pattern of histone mod-
iﬁcations to that seen in young ﬁbroblasts [53]. This very exciting
result indicates that the telomere length mitotic ’’age clock’’ is con-
trolling the deterioration of the global chromatin structure with
age, and that chromatin is likely to be a key mediator of the aging
process.
4. Conclusion
Growing evidence strongly implicates chromatin structure in
the aging process. Aging is accompanied by changes in the chroma-
tin structure, which is likely to impact all nuclear processes. As
such, maintenance of chromatin structure is integral for maintain-
ing proper cellular function during the aging process. Recent stud-
ies in budding yeast and human ﬁbroblast cells show that
chromatin is profoundly altered during aging due to the decreased
level of histone proteins and changes to abundance of histone
modiﬁcations. These alterations are likely to result in a more open
chromatin structure during aging, presumably allowing inappro-
priate transcription. The identiﬁcation of the speciﬁc transcripts
that are misregulated as a consequence of the altered chromatin
structure during aging that are causative for aging will provide a
better understanding of the fundamental molecular basis of the
aging process. Restoration of the aging chromatin structure back
to a more youthful state by elevating histone expression, reducing
H4 K16 acetylation, reducing H3 N-terminal acetylation, inactiva-
tion of the HDAC Rpd3, or blocking the signaling of persistent
DNA damage from shortened telomeres, is sufﬁcient to extend life-
span or revert the aged phenotype to a more youthful state. We ex-
pect that future studies will focus on understanding the molecular
consequences of these manipulations that tighten the loose chro-
matin structure of old cells, in order to extend lifespan. Only in thisway will the ﬁeld be able to develop speciﬁc therapeutics to extend
lifespan without the side effects that are likely to occur as a conse-
quence of tightening the chromatin structure of the entire genome.
It is certainly an exciting time for research at the intersection of
aging and chromatin structure.
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